Homologous Type of Malignant Mixed Mullerian Tumor of the Uterus Presenting as a Cervical Mass  by Kuyumcuoğlu, Umur & Kale, Ahmet
J Chin Med Assoc • October 2009 • Vol 72 • No 10 533
Introduction
Uterine sarcoma is a malignant tumor that arises from
the smooth muscle or connective tissue of the uterus.
Uterine sarcomas are rare neoplasms of the female
genital tract. They have aggressive clinical behavior
and a poor prognosis. The most common histological
types are represented by leiomyosarcoma, endometrial
stromal sarcoma, and carcinosarcoma (also known as
malignant mixed Mullerian tumor). Carcinosarcomas
are unusual forms of a phenotypic presentation of
uterine sarcomas. Carcinosarcomas are defined as
tumors exhibiting a malignant epithelial component in
association with a malignant stromal component; the
latter may be homologous or heterologous to the native
components of the uterus. Carcinosarcomas account
for approximately 2–5% of all malignancies of the
uterine corpus. Carcinosarcomas are rare neoplasms and
usually associated with poor prognosis. Total abdomi-
nal hysterectomy and bilateral salpingooophorectomy
and pelvic/paraaortic lymphadenectomy are optimal
therapy for carcinosarcoma.1,2
Here, we describe an interesting case of carcino-
sarcoma (homologous type of malignant mixed tumor
of the uterus) that presented as a cervical mass.
Case Report
A 55-year-old postmenopausal woman was referred
to our clinic with a diagnosis of cervical mass. Her
past medical history included no operation or systemic
illness. Her presenting symptom was postmenopausal
bleeding. On general examination, she was afebrile,
with a blood pressure of 110/72 mmHg and a pulse
rate of 84 beats/min. Abdominal examination was nor-
mal. Gynecologic examination revealed a 4 × 4 × 5 cm
mass that protruded from the cervix (Figure 1). The
patient’s hematologic workup demonstrated hemo-
globin of 12.0 g/dL, hematocrit of 34.1%, white
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blood cell count of 2.17/mm3, and platelet count of
122,000/mm3. These findings suggested the possi-
bility of cervical myoma. Surgical management was
planned.
The patient was taken to the operating room where
the mass was excised by wide local excision under
general anesthesia in the lithotomy position. Frozen
section revealed that the mass was malignant. The 
decision was made to continue the operation, and we
performed total abdominal hysterectomy, bilateral
salpingo-oophorectomy and surgical staging (includ-
ing peritoneal washings, suspicious areas or peritoneal
surfaces sampled, infracolic omental sampling, pelvic and
paraaortic lymph node sampling, and appendectomy).
The patient was transferred to the intensive care
unit after surgery. She made a good recovery within
48 hours and was transferred to the gynecology unit.
She was discharged home in good health 10 days after
the operation. Histopathology showed a carcinosarcoma
(Figure 2). FIGO stage was IIA, pelvic and paraaortic
lymph nodes were negative, peritoneal washing cytol-
ogy was negative, sampling biopsies from the staging
surgery were negative, and the tumor was extended
to the endocervical glands.
The patient was referred to the oncology unit for
adjuvant postoperative radiotherapy. She remained
without evidence of recurrent disease 18 months after
surgical resection and pelvic radiation treatment.
Discussion
Carcinosarcomas of the cervix are rare neoplasms,
and only a few cases have been reported in the litera-
ture. Most of these cases were postmenopausal, with
the most frequent symptom being postmenopausal
bleeding—occurring in 90% of cases. Carcinosarcoma
grows as a large, soft, polypoid mass filling and dis-
tending the uterine cavity. On physical examination,
uterine enlargement is present in 50–95% of patients,
and a polypoid mass may be seen within or protrud-
ing from the endocervical canal in approximately 50%
of patients.1–3 Our patient’s gynecologic examination
revealed a 4×4×5cm mass protruding from the cervix.
Concerning etiologic factors, radiation exposure
to the pelvic area, infection with human papilloma
virus 16, obesity, nulliparity, and exogenous estrogen
use might have an effect on the development of carci-
nosarcoma.4 Spread of carcinosarcomas is primarily
via the lymphatic system. The most frequent areas of
spread are to the pelvis, lymph nodes, lungs and liver.
This metastatic route suggests that carcinosarcomas
spread by local extension and regional lymph node
metastasis, as with endometrial adenocarcinoma.2,3
Bulky tumors, vaginal and parametrial metastases have
been observed in carcinosarcomas of the cervix more
frequently than in other epithelial malignancies. Spread
of the disease at diagnosis can explain the poor prog-
nosis related to carcinosarcomas.2 Abell and Ramirez
reported a clinicopathologic review of 26 sarcomas 
of the uterine cervix, and found that the median
length of survival of the patients was just 11 months.5
Another study found that in patients with carcinosar-
coma confined to the uterine corpus (stage 1), the 
2-year survival rate was 53%, whereas the survival rate
dropped to 8.5% when the disease had extended to
the cervix, vagina or parametria (stages II and III).6
Treatment of uterine sarcomas should include hys-
terectomy, bilateral salpingo-oophorectomy, and treat-
ment of the pelvic lymphatics by irradiation or surgery.3
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Figure 1. A 4 ×4 ×5 cm mass protruding from the cervix.
Figure 2. Histopathology shows a carcinosarcoma.
Pelvic and/or paraaortic lymphadenectomy is indi-
cated for carcinosarcoma, which has a relatively high
incidence of lymph node metastasis.1–3 Lymph-
adenectomy appears to be important for this malig-
nancy, in order to discover occult metastatic disease
and to provide patients with a therapeutic benefit.
Carcinosarcoma also requires comprehensive peritoneal
surgical staging, including peritoneal cytology, omen-
tectomy, peritoneal biopsies, and, when appropriate,
tumor debulking.1–6 We performed total abdominal
hysterectomy and bilateral salpingo-oophorectomy and
surgical staging (including peritoneal washings, suspi-
cious areas or peritoneal surfaces sampled, infracolic
omental sampling, pelvic and paraaortic lymph node
sampling, and appendectomy) in our patient. She was
referred to the oncology unit for adjuvant postopera-
tive radiotherapy. She remained without evidence of
recurrent disease 18 months after surgical resection
and pelvic radiation treatment.
In conclusion, we have described a rare case of car-
cinosarcoma (homologous type of malignant Mullerian
tumor) of the uterus that presented as a cervical mass.
When a postmenopausal woman is admitted to the
gynecology department with a diagnosis of a cervical
mass, the clinician should keep in mind that the mass
may be a carcinosarcoma, and preoperative work-up
and surgical management should be performed as
appropriate.
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